Trial Profile
Phase 1 study of Zika vaccine in patients with zika infection
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 05 May 2016
At a glance
- Drugs Zika virus vaccine-Pharos (Primary)
- Indications Zika virus infection
- Focus Adverse reactions
- 05 May 2016 New trial record
- 02 May 2016 According to Pharos Biologicals media release, company will initiate this study by autumn of 2016.
Most Recent Events
Trial Overview
Purpose
This study will investigate the effect of Zika vaccine in patients with zika infection.
Diseases Treated
| Indication | Qualifiers | Patient Segments |
|---|---|---|
| Zika virus infection | treatment | - |
Subjects
- Subject Type patients
- Sex male & female
- Age Group adult
Patient Inclusion Criteria
- patients with zika infection
Trial Details
Organisations
- Affiliations Pharos Biologicals
Trial Dates
Other Details
- Design prospective
- Phase of Trial Phase I
- Location Unknown
- Focus Adverse reactions
Interventions
| Drugs | Route | Formulation |
|---|---|---|
| Zika virus vaccine-PharosPrimary Drug |
-
|
-
|
Zika-virus-vaccine
Trial History
| Event Date | Event Type | Comment |
|---|---|---|
| 05 May 2016 | New trial record | New trial record Updated 05 May 2016 |
| 02 May 2016 | Other trial event | According to Pharos Biologicals media release, company will initiate this study by autumn of 2016. Updated 05 May 2016 |
References
-
Pharos Biologicals. Pharos Biologicals Conducting Tests of a Novel Zika Vaccine. Media-Rel 2016;.
Media Release
Adis International Ltd. Part of Springer Science+Business Media
© Springer Nature Switzerland AG